Biobase 240t/H Automatic Chemiluminescence Immunoassay System Analyzer

Name: Biobase 240t/H Automatic Chemiluminescence Immunoassay System Analyzer
Brand: Biobase Biozone Co., Ltd.
SKU: 1909524675

Shandong, ChinaBiobase Biozone Co., Ltd.

US$20,000.00-26,000.00

1 Piece

Product profile

Customization

Available

Classification

Biochemical Apparatus

Type

Biochemistry Analyzer

Model NO.

BKI2200

Certification

Group

Middle-aged and Old

Model

Bki2200

Throughput

240t/H

Principle

Magnetic Particle Enzymatic Chemiluminescence

Modes of Operation

Random, Batch and Stat

Separation Method

Magnetic Separation Technology

Sample Positions

60 (Each Position Could Be Used as an Emergency Po

Reagent Positions

30 PCS (2-8℃ Refrigeration)

Incubation Positions

Time to 1st Result

18 Minutes

Sample Volume

15-100

Detection Precision

CV<=5%

Carry-Over Rate

<=10-5

Correlation Coefficient

R>=0.99

Calibration Stability

28 Days

Calibration Type

6/7-Point Calibration

Transport Package

Wooden Case or Carton Package

Specification

1608*898*1534mm

Trademark

BIOBASE

Origin

China

Production Capacity

1000units/Month

Company profile

High Repeat Buyers ChoiceExhibition ExperienceMulti-language PioneerExperienced Team

Biobase Biozone Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8 years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤2.97h

AI-Powered supplier vetting

SummaryThe supplier is identified as a combined company with eight production lines, reported annual productivity of 500,000 medical freezers, and two quality inspectors. It demonstrates broad customization and ODM capabilities, has introduced new products within the past year, and provides OEM services for well-known brands. Service procedures for supplier capability, corrective and preventive actions, and customer complaints are documented and supported by records. Overseas support includes installation, training, repair, debugging, and maintenance, with inventory and an overseas warehouse available. However, the supplier lacks overseas agents or branches, an overseas showroom, and a valid manufacturing-capacity contract with related subcontractors. Quality-control limitations include finished-product checks performed by packing staff and no continuous batch quantity reconciliation or outsourcing SOP. The supplied information does not establish certifications, financial strength, or specific customer case details.

Supplier typeThe supplier is explicitly classified as a combined company and is not an offshore company. The available information does not further define its ownership structure or operating model.

After-Sales capabilityThe supplier has documented procedures and records for handling customer complaints and corrective/preventive actions, and offers overseas installation, training, repair, debugging, and maintenance. It also reports inventory and an overseas warehouse, but has no overseas agents or branches and offers services in zero stated countries.

R&D capabilityThe supplier reports new products within the past year, provides ODM services, and supports multiple forms of design customization. ERP-based digital management is also reported, while no SDK is available; overall evidence supports product-development capability but not software-development capability.

Production capacityThe supplier reports eight production lines and annual productivity of 500,000 medical freezers, with inventory and overseas warehouse capability. Important controls are incomplete: there is no valid manufacturing-capacity contract with related subcontractors, no continuous batch quantity reconciliation, and no outsourcing SOP.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization, supported by stated R&D and ODM capabilities. This is direct evidence of broad customization coverage.